Health Care/Hospital
Jacobio Receives CDE Approval for Glecirasib's Pancreatic Cancer Pivotal Study in China
BEIJING, SHANGHAI and BOSTON, July 4, 2023 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its novel KRAS G12C inhibitor glecirasib's pivotal study for pancreatic cancer has been approved from CDE (Center for Drug Evalu...
2023-07-04 21:16
2156
Positive guidance from US FDA on Cu-64 SAR-bisPSMA Phase III trial in prostate cancer
Highlights * FDA agreement for a pivotal Phase III trial for 64Cu SAR-bisPSMA diagnostic in prostate cancer * Phase III trial design based on 64Cu SAR-bisPSMA data package, including positive results from the completed PROPELLER trial * A total of 383 prostate cancer patients to take part ...
2023-07-04 20:55
2142
China NMPA approves RareStone's pitolisant (Wakix) for the treatment of narcolepsy
-- pitolisant is the first and only treatment drug approved in mainland China for narcolepsy. SHANGHAI, July 4, 2023 /PRNewswire/ -- RareStone Group, a rare disease-focused company aiming to establish the first rare disease ecosystem in China, announced that on June 30, the Chinese National Med...
2023-07-04 20:42
1832
Chula Researchers Find "Extreme Stress and Depression" Chemicals in Sweat and Successfully Test Firefighters' Mental Health for the First Time!
BANGKOK, July 4, 2023 /PRNewswire/ -- Further to the success of the COVID-19 sweat test, Assistant Professor Dr.Chadin Kulsing, Department of Chemistry, Faculty of Science, in collaboration with Dr. Patthrarawalai Sirinara, MD, MPH Department of Preventive and Social Medicine, Faculty of Medicin...
2023-07-04 16:59
2694
PETCUBES INTRODUCES GROUNDBREAKING 'VETERINARY SUPPORT DIET' RANGE FOR DOGS WITH SPECIAL HEALTH NEEDS
* Revolutionary Range Of Nutrient-Rich Meals Trialled In Collaboration With Temasek Polytechnic, Designed To Support Unique Nutritional Requirements Of Pets With Specific Health Conditions * Veterinary Support Diet Range is Gently Cooked, which effectively kills any possible contaminants whil...
2023-07-04 14:00
1994
PharmaLedger Reaches 30+ Members Demonstrating the Ecosystem Trend in Digital Health
BASEL, Switzerland, July 4, 2023 /PRNewswire/ -- The PharmaLedger Association,
a pioneering nonprofit organization dedicated to fostering a secure and reliable
Digital Trust Ecosystem
2023-07-04 10:30
2299
AFTER FIVE YEARS OF SUCCESSFUL EXPERIENCE INTERNATIONALLY, BIOCON BIOLOGICS' HULIO® BIOSIMILAR TO HUMIRA®, NOW AVAILABLE IN THE UNITED STATES
BRIDGEWATER, N.J. and BENGALURU, India, July 3, 2023 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, today announced that HULIO® (adalimumab-fkjp) injection, a biosimilar to Humira® (adalimumab), is now available to patients inthe United States after five years of experien...
2023-07-04 01:22
2181
Lumos Receives US FDA Clearance for FebriDx®
MELBOURNE, Australia, July 3, 2023 /PRNewswire/ -- Lumos Diagnostics (ASX: LDX), ("Lumos" or the "Company") a leader in rapid, point-of-care (POC) diagnostic technologies, is pleased to announce that it has received clearance from the US Food and Drug Administration (FDA) to market its FebriDx® r...
2023-07-03 21:50
2443
Lunit's AI-Powered Lung Cancer Screening Solution Significantly Affects Radiologists' Diagnostic Determination - Published in Radiology
- Recent study conducted by Seoul National University Hospital provides strong evidence that high-accuracy AI model improves radiologists' chest X-ray analysis performance SEOUL, South Korea, July 3, 2023 /PRNewswire/ -- Findings from a recent study demonstrate that medical AI solutions with onl...
2023-07-03 21:00
2044
Skyline Therapeutics Receives FDA Clearance of IND for SKG0106, a Novel Intravitreally Delivered AAV Gene Therapy Candidate for Neovascular Age-related Macular Degeneration
SHANGHAI and BOSTON, July 3, 2023 /PRNewswire/ -- Skyline Therapeutics, an innovation-driven gene therapy company committed to developing unique and novel solutions for rare and severe diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New D...
2023-07-03 19:00
1489
Henlius Forecasts Profit in 1H 2023
Spurring a Seamless R&D, Manufacturing, and Commercialisation Positive Cycle SHANGHAI, July 3, 2023 /PRNewswire/ -- Henlius (2696.HK) released a positive profit forecast. Based on the preliminary assessment of the unaudited comprehensive management accounts for the six months endedJune 30, 2023, ...
2023-07-03 18:59
4156
Singapore Hosts the 25th World Congress of Dermatology - The First in Southeast Asia, Drawing Over 11,000 Delegates to Discuss New Developments in Skin Research and Treatments
Themed 'Dermatology Beyond Borders', WCD2023 is one of the largest international medical conventions in the region, and is set to gather over 11,000 local and foreign delegates, including clinicians, scientists, other health-care professionals and industry partners across 130 countries to unveil ...
2023-07-03 18:29
2364
Henlius Forecasts Profit in 1H 2023
Spurring a Seamless R&D, Manufacturing, and Commercialisation Positive Cycle SHANGHAI, July 3, 2023 /PRNewswire/ -- Henlius (2696.HK) released a positive profit forecast. Based on the preliminary assessment of the unaudited comprehensive management accounts for the six months endedJune 30, 2023, ...
2023-07-03 17:49
2202
SHL Medical acquires 100% of the shares in Swiss company LCA Automation
SHL Medical announces the acquisition of LCA Automation AG, a Swiss innovative automation solutions provider. The acquisition is SHL Medical's response to the growing market demand for drug delivery solutions and will support its manufacturing operations globally, especially the upcomingSwiss man...
2023-07-03 17:00
2125
Cigna Healthcare Hong Kong Takes Cigna VHIS Series - Flexi Plan (Superior) to the Next Level with Upgraded Offerings for New and Existing Customers
Customers to enjoy new features including accidental emergency dental and emergency outpatient treatment benefits HONG KONG, July 3, 2023 /PRNewswire/ -- Cigna Healthcare Hong Kong today announced the launch of its upgraded Cigna Voluntary Health Insurance Scheme (VHIS) Series - Flexi Plan (Supe...
2023-07-03 16:12
2085
Alma, a Sisram Medical company, is establishing a direct operation in China after completing the acquisition of PhotonMed
HONG KONG, July 3, 2023 /PRNewswire/ -- Alma, the world leader and innovator in providing energy-based medical and aesthetic solutions and a wholly-owned company by Sisram Medical (1696.HK), announced today that it has completed the acquisition of PhotonMed International Ltd ("PhotonMed"), the le...
2023-07-03 15:48
4144
Ping An Asset Management No.36 in Top 500 Asset Managers 2023
HONG KONG and SHANGHAI, July 3, 2023 /PRNewswire/ -- Ping An Asset Management Co., Ltd. (PAAMC), a subsidiary of Ping An Insurance (Group) Company ofChina, Ltd. ("Ping An" or the "Group", HKEx:2318; SSE:601318) ranked 36th in the world in the Top 500 Asset Managers 2023 list from Investment & Pen...
2023-07-03 14:46
4960
Fair Play Menarini International Awards, the 2023 edition starts with the talk show "The Champions tell their Stories" in Piazza della Signoria, Florence
FLORENCE, Italy, July 3, 2023 /PRNewswire/ -- The countdown has begun to the XXVII edition of the Fair Play Menarini International Awards. Tomorrow, Monday, July 3rd, the 2023 edition of the event, dedicated to the sporting values of ethics, fair play and respect, will officially begin in the cit...
2023-07-03 09:31
2138
Zymedi announced their collaboration with the National Heart, Lung, and Blood Institute through a CTA CRADA to develop ZMA001 mAb, a potential treatment for Pulmonary Arterial Hypertension (PAH), a rare, female predominant disease
SEOUL, South Korea, July 2, 2023 /PRNewswire/ -- Today Zymedi, a Korean biotech venture-backed company, announced the signing of a clinical Cooperative Research and Development Agreement (CRADA) with the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health ...
2023-07-03 08:00
2611
Innovent and IASO Bio Announce the NMPA Approval of FUCASO®, the First Fully-human BCMA CAR-T Therapy, for the Treatment of Relapsed or Refractory Multiple Myeloma
ROCKVILLE, Md. and SUZHOU, China, July 3, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...
2023-07-03 08:00
3896
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 328 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 321 media titles]
2024-05-15 12:00
Innomix and World Castle Association Pioneer LBMR project at Zhangbi Fortress
[Picked up by 320 media titles]
2024-05-20 13:48
Samsung Electronics Unveils Month-Long Celebration of Esports Events for Students in Southeast Asia
[Picked up by 318 media titles]
2024-05-21 08:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 308 media titles]
2024-05-16 15:00
Most Read
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
2024-05-16 15:00
14360
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
2024-05-15 12:00
14100
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
2024-05-16 09:39
12922
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
2024-05-17 07:00
12330
Casio to Release G-SHOCK-Surfrider Foundation Collaboration
2024-05-15 09:00
10993
